Passage BIO, Inc. Reports on Security Holder Vote
Ticker: PASG · Form: 8-K · Filed: May 30, 2025 · CIK: 1787297
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
TL;DR
Passage BIO held a security holder vote on 5/28, details TBD.
AI Summary
Passage BIO, Inc. filed an 8-K on May 30, 2025, reporting on a matter submitted to a vote of its security holders on May 28, 2025. The filing does not disclose the specific details of the vote or the outcome.
Why It Matters
This filing indicates a significant event where security holders voted on a matter, which could impact the company's future direction or governance.
Risk Assessment
Risk Level: medium — The filing concerns a vote by security holders, which can lead to changes in corporate governance or strategy, but the lack of specific details makes the immediate risk unclear.
Key Players & Entities
- Passage BIO, Inc. (company) — Registrant
- May 28, 2025 (date) — Date of earliest event reported
- May 30, 2025 (date) — Filing Date
- Delaware (jurisdiction) — State of incorporation
- Philadelphia, PA (location) — Principal executive offices
FAQ
What specific matter was submitted for a vote to Passage BIO, Inc. security holders on May 28, 2025?
The filing does not specify the exact matter that was submitted for a vote.
What was the outcome of the security holder vote on May 28, 2025?
The filing does not disclose the results or outcome of the vote.
When was this 8-K form filed with the SEC?
This 8-K form was filed on May 30, 2025.
What is Passage BIO, Inc.'s principal executive office address?
Passage BIO, Inc.'s principal executive offices are located at One Commerce Square, 2005 Market Street, 39th Floor, Philadelphia, PA 19103.
What is Passage BIO, Inc.'s telephone number?
Passage BIO, Inc.'s telephone number is (267) 866-0311.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 30, 2025 regarding Passage BIO, Inc. (PASG).